Evaluation knowledge, attitude, and behaviour for breast cancer among young women living in two different habitats of Turkey
Özet
Background: Breast cancer is the most frequently diagnosed cancer among women in Turkey and worldwide, and is ranked as the second-leading cause of death in women after lung cancer. Early diagnosis of breast cancer is possible, and breast cancer is included in cancer-screening programs in Turkey. The aim of this study was to evaluate the knowledge, attitude, and behaviour of young women (older than 20 years of age) on breast self-examination and breast cancer screening methods, and to determine the effect of sociodemographic characteristics. Methods: A total of 489 patients were included in the study. The mean age of participants was 36.53 ± 11.22 years. 346 (70.8%) of the participants were married. The study was a cross-sectional, non-randomized study in public health. The participants in this study were women over 20 years old, who presented to Arnavutkoy State Hospital General surgery policlinic and Sisli Hamidiye Etfal Family Medicine policlinic. Results: The rate and duration of breastfeeding were higher among participants living in rural areas than those living in urban areas (p < 0.001) The awareness of breast cancer increased as the level of education increased (p < 0.001). Having a family history of a high incidence of breast cancer significantly increased the rate of breast self examination practice by 1.93 fold (p=0.016). Conclusion: Breast Cancer is a disease that can be treated 100 % with early diagnosis. Primary care physicians especially works in lower socioeconomic conditions have to tell the importance of early diagnosis of breast cancer, and properly explain breast self examination and other screening tools. © 2018 Asian Pacific Organization for Cancer Prevention.
Cilt
19Sayı
11Koleksiyonlar
İlgili Öğeler
Başlık, yazar, küratör ve konuya göre gösterilen ilgili öğeler.
-
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Karaçın, Cengiz; Öksüzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Baytemur, Naziyet Köse; Yılmaz, Funda; Selvi, Oğuzhan; Karaboyun, Kubilay (BioMed Central Ltd, 2023)Background: There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which ... -
Bioinformatic Analysis and in Vitro Validation of Let-7b and Let-7c in Breast Cancer
Bozgeyik, Esra (Elsevier Ltd, 2020)Members of the let-7 family of miRNAs are well-known with their tumor suppressor properties as they are expressed at low levels in several types of human malignancies. Among them, let-7b and let-7c have gained special ... -
Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer
Yıldız Tacar, Seher; Bozgeyik, Esra; Şeber, Erdoğan Selçuk; Yetişyiğit, Tarkan; Tozkır, Hilmi; Avcı, Okan; Arslan, Ahmet (Elsevier Inc., 2020)Mutations in two major breast cancer susceptibility genes, BRCA1 and BRCA2, have been identified to be the most important predisposing factors for the development of breast cancer. Thus, BRCA1/2 testing is a well-established ...